A study published in Nature Nanotechnology has introduced a new wearable biosensor for monitoring fertility hormones, notably oestradiol, in human sweat. This device, resembling a ring and worn on the finger, offers a non-invasive alternative to traditional blood tests for hormone monitoring. The biosensor combines microfluidics, nanoelectronics, and a class of molecules known as aptamers. These aptamers, short strands of DNA or…
Bayer and CrossBay Medical have announced a development and licensing agreement to create a single-handed inserter for intrauterine systems (IUS), integrating CrossBay’s CrossGlide technology with Bayer’s hormonal IUD portfolio. One of the challenges in IUD insertion is the pain and discomfort experienced by some women. The process, which involves inserting a small T-shaped device into the uterus, can cause pain and cramping,…
Pharmavite, known for its Nature Made vitamins, has expanded its presence in the women’s health market with the acquisition of Bonafide Health for $425 million. This move adds Bonafide Health, alongside Uqora and Equelle, to Pharmavite’s portfolio, reinforcing its status as a frontrunner in providing innovative and science-backed health solutions for women. Founded in 2017, Bonafide Health has been working on creating…
The National Menopause Foundation has announced the launch of the Women’s Midlife Health Policy Institute (WMHPI), an initiative aimed at improving research, education, and policy development focused on women’s health during midlife, specifically addressing the challenges of menopause. In the United States, about 1.3 million women enter menopause each year, and by 2025, the number of postmenopausal women worldwide is expected to…
Recently, a PR agency’s pitch landed in my inbox, discussing the future of AI in adult entertainment. Initially, it seemed peripheral, if not irrelevant. But as I nearly dismissed it, a realization dawned on me: The adult entertainment industry has consistently been at the forefront of technological adoption and innovation. And considering my recent discussions on the overlap of innovations across industries,…
Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Endometrial cancer diagnostics company MiMARK secures €4.22M in seed funding. Food-as-medicine platform startup Season acquires clinical assets from Wellory. Pioneer Life Sciences Fund invests in at-home fertility care company Béa Fertility. GE launches MyBreastAi Suite,…
Vella Bioscience, a biotech startup focusing on women’s sexual health, has launched the Consortium for the Study of Women’s Sexual Wellness. The initiative, chaired by Dr. Harin Padma-Nathan, former lead clinical researcher for Viagra, aims to enhance female sexual health through rigorous scientific research. The Consortium brings together ten experts to develop non-pharmaceutical tools for female sexual health, concentrating on areas like…
GE HealthCare has announced the release of MyBreastAI Suite, a new AI-powered platform for mammography, designed to aid clinicians in detecting breast cancer. This platform integrates AI applications from iCAD, focusing on breast density assessment and enhancing the efficiency of mammography workflows. Addressing the challenges posed by the global rise in breast cancer cases, MyBreastAI Suite aims to streamline breast cancer detection.…
